Talks.cam will close on 1 July 2026, further information is available on the UIS Help Site
 

University of Cambridge > Talks.cam > Cambridge Immunology Network Seminar Series > Harnessing NK cell metabolism for cancer immunotherapy

Harnessing NK cell metabolism for cancer immunotherapy

Add to your list(s) Download to your calendar using vCal

  • UserProf Clair Gardiner, Professor in Immunology, Trinity College Dublin World_link
  • ClockThursday 04 December 2025, 16:00-17:00
  • HouseCRUK CI Lecture Theatre.

If you have a question about this talk, please contact Liat Churley.

This Cambridge Immunology Network Seminar will take place on Thursday 4 December 2025, starting at 4:00pm, CRUK Lecture Theatre

Speaker: Clair Gardiner, Professor in Immunology, School of Biochemistry and Immunology, Trinity College Dublin

Title: “Harnessing NK cell metabolism for cancer immunotherapy”

Short Bio: Professor Clair Gardiner is a Prof. in Immunology at Trinity College Dublin, Ireland. Based in the School of Biochemistry and Immunology since 2002, she is the Head of the Discipline of Immunology. Along with teaching and other admin duties, Prof. Gardiner has an active and dynamic research lab. She is an internationally recognized leader in the field of natural killer (NK) cell biology. Her research focuses on understanding how NK cell metabolism and signalling influence immune responses in cancer and immunotherapy. Over the past ten years, her group has made key contributions to elucidating the metabolic regulation of NK cell function, including the first ever paper published on human NK cell metabolism. Using patient cohorts from a variety of cancer types, the group seek to understand the mechanisms of NK cell metabolic dysregulation in cancer patients, understanding the impact of the TME on circulating NK cells and to translate these insights toward improving cancer immunotherapy. With over 60 peer-reviewed publications in leading journals including JITC , PNAS, Journal of Immunology, and Gut, Professor Gardiner’s work has been cited more than 3200 times. Her recent studies have uncovered how metabolic pathways—including those regulated by TGF β and PKM2 —shape NK cell responses in cancer, advancing the field of immunometabolism.

Host: Maike de la Roche, CRUK

Refreshments will be available following the seminar.

This talk is part of the Cambridge Immunology Network Seminar Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity